TaaS 2.0 is an online event that shows users how to improve their financial portfolio by investing in smart-car technology. The event is hosted by Whitney Tilson, who will be explaining the benefits of Transportation as a Service (TaaS) stocks.
What is TaaS 2.0?
There are many different ways that consumers can invest today, even though stocks tend to be the trade of choice. However, they are far from the only option. TaaS – or Transportation as a Service – is an innovative opportunity, and it is currently driving the world of vehicle technology. Whitney Tilson, the founder of a research company called Empire Financial Research, recently decided to bring more awareness to the way that this opportunity could bring in major funding.
TaaS introduces the idea that autonomous and fully electric cars could soon be found in every major city in the country. In fact, the tech that supports it could make it possible for these vehicles to travel over 500 miles each year before they even need to be charged again. Though a little maintenance may be necessary, they are made to function for a minimum of 100,000 miles. With this widespread use, anyone will be able to use an app on their phone to use one as their own transportation service, much in the same way that Lyft and Uber are used.
If applied properly, these innovations could bring thousands of dollars back to the pockets of each family. Parking lots could become obsolete, and the value of different properties might skyrocket. Whitney discovered the possibility for this incredible change just a few years ago, but he had no idea what he was in store for. He even published a video about it online last year.
Since the video was put up, it’s already been seen millions of times, educating people around the world about the possibilities of TaaS. The stocks for the companies working on TaaS saw an incredible jump with this knowledge, rising up by over 400% on average. Whitney admits that he wasn’t the person behind the recommendation of these 20 stocks, but the recommendations that he offered made it possible for the average individual to double their profits twice in 2020.
Still, the world of technology is constantly evolving. The trades of yesterday are nothing like the trades of today, and Whitney believes that the next 12 months will bring incredible changes that could be highly profitable. The TaaS stocks are set to rise in a second phase, and Whitney wants to ensure that no one is left behind.
Registering for the TaaS 2.0 Event
Since the TaaS 2.0 event is entirely free to attend, and all users need to do is sign up on the official website to keep their place in the event. Since it is hosted online, users have to register to be considered a part of program. They can take notes, make investments with the recommendations, and more.
Once registered, the user will receive reminders about the event, which will take place on March 25th at 8:00pm. Along with the information provided by Whitney, the event will also be accompanied by Enrique Abeyta, which is a colleague of his.
Once the user is signed up, they just have to tune in on time to see this event on March 25th.
For More Information
As much information as there is online, users can always reach out to the customer service team at Empire Financial Research to learn more. The customer service team can be reached by filling out the form at https://empirefinancialresearch.com/contact.
Affiliate Disclosure:
The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products.
Disclaimer:
Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.
